David Baker Lab Uses AI to Design Precision Kinase Regulators
DaveJuergens · x · 2026-07-15
The David Baker Lab has successfully used AI to design genetically encoded small proteins that directly regulate kinase activity.
- Breakthrough: Kinase structures are highly similar, causing traditional inhibitors to easily miss targets. The designed proteins directly target the kinase catalytic domain rather than traditional allosteric sites.
- Experimental Data: 96 binding proteins were designed for FAK kinase, 33 of which showed regulatory activity. Among the top 4, 2 inhibited FAK at low nanomolar levels, and 2 increased activity by over 2-fold.
- Cellular Validation: Expressing these proteins in living cells successfully replicated in vitro kinase inhibition/activation effects and rewrote intracellular signaling.
- Expansion Potential: Leveraging structural similarities, the team adapted FAK inhibitors into Src kinase inhibitors, providing a universal design blueprint for kinase-targeted drugs.
More from Research
- Structural ensembles beat single predictions in TCR:pMHC generalization study — quaidmorris · 2026-07-22
- RSS launches under OMSF to push structural biology data modeling at scale — MoAlQuraishi · 2026-07-22
- enFoldX tops 8 neoantigen scans and an unseen-peptide benchmark — quaidmorris · 2026-07-22
- enFoldX reaches AUC 0.82 on human VDJdb and transfers to mouse at 0.76 — quaidmorris · 2026-07-22
- enFoldX gains accuracy as AF3 ensemble disagreement rises for non-binders — quaidmorris · 2026-07-22
- A 3D ray plot shows how hard this Jacobian counterexample is to read — moultano · 2026-07-22